#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital myopathy Myotonic dystrophy Angiosarcoma Adrenocortical carcinoma Infection in an immunocompromised host Myelodysplastic syndrome with excess blasts Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Mantle cell lymphoma recurrent Spina bifida Stress cardiomyopathy Asthma Leukoencephalopathy Mixed-type liposarcoma Hereditary angioedema Corneal neovascularisation More trials…

    Learn about Rare Diseases

    Synovial sarcoma metastatic – Diagnostics Pleomorphic leiomyosarcoma – Treatment Mucopolysaccharidosis II – Trials in Disease Lymphangioma – Treatment Lysosomal storage disorder – Treatment Burkitt’s lymphoma – Life with Disease Congenital generalised lipodystrophy – Treatment Niemann-Pick disease – Life with Disease Ehlers-Danlos syndrome – Treatment Amyotrophic lateral sclerosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lecanemab Collagenase Cerebrolysin Concentrate Fianlimab Anhydrous Glucose Bp Betamethasone Dipropionate Temocillin Sodium ZIGAKIBART Gallium (68Ga) Chloride Sodium Acetate Trihydrate Edotreotide Treprostinil Sodium Rbl035.2 Dexchlorpheniramine Trametinib Setrusumab Exagamglogene Autotemcel Protein C Febuxostat Tiemonium Methylsulphate More therapies…

    Learn about Your Condition

    Primary hypogonadism Cardiac valve disease High-grade B-cell lymphoma Dengue fever Adrenal insufficiency Chronic fatigue syndrome Benign renal neoplasm Neck pain Immunosuppression Hydrocele Oral herpes Anorexia nervosa Small fibre neuropathy Metastases to biliary tract Relapsing multiple sclerosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Spitalul Clinic De Urgenta Pentru Copii Sfanta Maria…

Spitalul Clinic De Urgenta Pentru Copii Sfanta Maria Iasi

Strada Vasile Lupu Nr 62, Iasi, 700309, Romania

Want to learn more about this study or check if you can participate? Contact us.

  • A study to evaluate the effectiveness and safety of clemizole hydrochloride as an additional treatment for patients with Lennox-Gastaut syndrome

    Recruiting

    3 1
    Investigated Diseases:
    • Lennox-Gastaut syndrome
    Investigated Drugs:
    • Clemizole Hydrochloride
    Czechia Hungary Italy Poland Romania Spain

  • A study testing fitusiran to prevent bleeding in boys aged 1 to 11 years with hemophilia A or B with or without inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Haemophilia
    Investigated Drugs:
    • Fitusiran
    Belgium Germany Hungary Italy Poland Romania +1

  • Study on Deucravacitinib for Children with Moderate to Severe Plaque Psoriasis

    Recruiting

    3 1
    Investigated Drugs:
    • Deucravacitinib
    France Germany Poland Romania Spain

  • Study on the Long-Term Safety of Brivaracetam for Children and Young Adults with Childhood or Juvenile Absence Epilepsy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Brivaracetam
    Italy Romania Slovakia Spain

  • Study on Lasmiditan for Treating Migraine in Children Aged 6 to 17

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Lasmiditan
    Belgium France Germany Italy The Netherlands Romania +1

  • Study of brivaracetam as a treatment for childhood and juvenile absence epilepsy in patients aged 2-25 years

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Brivaracetam
    Italy Romania Slovakia Spain

  • Study on the Safety and Tolerability of Lasmiditan for Treating Migraine in Children Aged 6 to 17

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Lasmiditan
    Belgium France Germany Italy The Netherlands Romania +1

  • Long-Term Safety Study of Lacosamide for Children with Epilepsy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • Lacosamide
    Hungary Romania

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!